Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1015

3’-sialyllactose sodium salt

Intended Use: Intended for use as an ingredient in formulas for young children aged 1-3 years, instant and ready-to-eat cereals for infants and young children under 3 years of age, milk-based meal replacement beverages for children, meal replacements drinks, non-alcoholic non-carbonated drinks, bars, oral electrolyte solutions, and enteral tube feeding formulas at levels ranging from 0.1 to 1.5 g/L or g/kg.
Basis: Scientific procedures
Notifier: Chr. Hansen, Inc.
Notifier Address: 9015 West Maple Street
Milwaukee, WI 53214
GRAS Notice (releasable information): GRN 1015 (in PDF) (3.5 MB)
FDA's Letter: Pending

96  
-
-